Mangoceuticals (MGRX) Change in Inventory (2023 - 2024)
Mangoceuticals (MGRX) reported Change in Inventory of -$806.0 for Q3 2024, up 57.87% on a YoY basis from -$510.56 in Q4 2023, and down 86.14% sequentially from -$433.0 in Q2 2024.
Mangoceuticals (MGRX) Change in Inventory (2023 - 2024) Analysis & Trends
Mangoceuticals (MGRX) has 2 years of Change in Inventory data on file, last reported at -$806.0 in Q3 2024.
- For the quarter ending Q3 2024, Change in Inventory rose 57.87% year-over-year to -$806.0; the trailing twelve-month figure through Sep 2024 stood at -$8368.0 (changed N/A YoY), and the FY2023 full-year result was $18501.0, changed N/A from the prior year.
- Change in Inventory eased to -$806.0 in Q3 2024, from -$433.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of -$433.0 in Q2 2024 to a low of -$4049.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | -254.83 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | -1.47 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | -2.70 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | -64.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | - |
| 10 | Mangoceuticals | 9.39 Mn | 9.20 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -806.00 |
| Sep 30, 2024 | -806.00 |
| Jun 30, 2024 | -433.00 |
| Jun 30, 2024 | -433.00 |
| Mar 31, 2024 | -4,049.00 |
| Mar 31, 2024 | -4,049.00 |
| Dec 31, 2023 | -3,080.00 |
| Dec 31, 2023 | -3,080.00 |
| Sep 30, 2023 | -1,913.00 |
| Sep 30, 2023 | -1,913.00 |